for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Beijing Tiantan Biological Products Corp

600161.SS

Latest Trade

27.48CNY

Change

-0.07(-0.25%)

Volume

5,009,641

Today's Range

27.36

 - 

27.80

52 Week Range

14.51

 - 

30.45

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
27.55
Open
27.55
Volume
5,009,641
3M AVG Volume
149.01
Today's High
27.80
Today's Low
27.36
52 Week High
30.45
52 Week Low
14.51
Shares Out (MIL)
1,045.37
Market Cap (MIL)
28,726.68
Forward P/E
46.41
Dividend (Yield %)
0.15

Latest Developments

More

Beijing Tiantan Biological Products Sees 6-Month Net Profit Up 23.9% Y/Y

Beijing Tiantan Biological Products Says 2018 Net Profit Down 56.6 Pct

Beijing Tiantan Biological Products Sees 2018 Net Profit Down 58 Percent Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Beijing Tiantan Biological Products Corp

BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.

Industry

Biotechnology & Drugs

Contact Info

No. 4

Sanjianfang Nanli, Chaoyang District

+86.10.65439720

http://www.tiantanbio.com

Executive Leadership

Xiaoming Yang

Chairman of the Board

Yi Zhang

Chief Financial Officer, Deputy General Manager

Daoxing Fu

General Manager

Bainian Fu

Deputy General Manager

Hongji Xu

Deputy General Manager

Key Stats

1.38 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

2.1K

2018

2.9K

2019(E)

3.5K
EPS (CNY)

2016

0.251

2018

0.483

2019(E)

0.592
Price To Earnings (TTM)
49.55
Price To Sales (TTM)
8.46
Price To Book (MRQ)
7.57
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
10.76
LT Debt To Equity (MRQ)
10.54
Return on Investment (TTM)
22.45
Return on Equity (TTM)
15.36

Latest News

Latest News

BRIEF-Beijing Tiantan Biological plans assets sales, acquisition

Beijing Tiantan Biological Products Corp Ltd

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up